all peptides were produced by solid state synthesis (fmoc chemistry) Search Results


90
Auspep Pty reagents and solvents (peptide synthesis grade)
Reagents And Solvents (Peptide Synthesis Grade), supplied by Auspep Pty, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/all+peptides+were+produced+by+solid+state+synthesis+(fmoc+chemistry)/solvent+a/pm09115267-58-3-10
Average 90 stars, based on 1 article reviews
reagents and solvents (peptide synthesis grade) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
CS Bio Inc cs-bio peptide synthesizer
Cs Bio Peptide Synthesizer, supplied by CS Bio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/all+peptides+were+produced+by+solid+state+synthesis+(fmoc+chemistry)/peptide+synthesizer/pmc02536683-559-12-12
Average 90 stars, based on 1 article reviews
cs-bio peptide synthesizer - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
CEM Corporation liberty automatic microwave peptide synthesizer
Liberty Automatic Microwave Peptide Synthesizer, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/all+peptides+were+produced+by+solid+state+synthesis+(fmoc+chemistry)/liberty+microwave+peptide+synthesizer/pm26204509-152-15-20
Average 90 stars, based on 1 article reviews
liberty automatic microwave peptide synthesizer - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
GenScript corporation custom synthesized peptides
Custom Synthesized Peptides, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/all+peptides+were+produced+by+solid+state+synthesis+(fmoc+chemistry)/custom+synthesized+peptides/pmc05218887-133-40-42
Average 90 stars, based on 1 article reviews
custom synthesized peptides - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
GenScript corporation hira peptide
a Heat map depicting amino acid selectivity at positions surrounding a Ser/Thr phosphorylation site determined from arrayed PSPL analysis of <t>TLK2</t> ΔN178. The heat map shows normalized, log2 transformed PSPL spot intensities averaged across two separate experiments. Numerical values are provided in Supplementary Table . b Sequence logos showing positively selected residues were generated from the data shown in a using Seq2Logo . c Sequences of previously reported phosphorylation sites on human ASF1a and ASF1b. d Relative rates of TLK2 ΔN178 phosphorylation of a synthetic consensus peptide substrate (top) and Ala substitution variants (bars show mean ± SD, n = 4 independent experiments). e Representative assay showing TLK2 ΔN178 phosphorylation of purified GST-tagged ASF1b-CT (residues 155-202) and ASF1b-CT mutants was assessed in kinase assays in vitro. A kinase inactive TLK2-D592A mutant was included as a control. f Quantified results from three independent replicates of the experiment shown in panel e (mean ± SD) (right). g Electrostatic surface potential of the TLK2 and PKA catalytic domains (PDB 5O0Y and 1ATP ) with overlayed peptide fragment from the PKA-PKI complex (PDB 1ATP) generated using Pymol. h Phosphorylation of purified GST-tagged FL ASF1b (FL), the N-terminal domain (NT, residues 1–155) or the C-terminal tail (CT, residues 155–202) by purified FL TLK2 (WT or kinase inactive D592A mutant) was assessed using in vitro kinase assays. Results from one representative experiment of two are depicted, along with a cartoon depicting ASF1b domain organization and major sites of phosphorylation. Source data are provided as a Source Data file.
Hira Peptide, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/all+peptides+were+produced+by+solid+state+synthesis+(fmoc+chemistry)/tlk2+peptide/pmc08826447-297-11-7
Average 90 stars, based on 1 article reviews
hira peptide - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
BIOTAGE initiator+ alstra peptide synthesizer
a Heat map depicting amino acid selectivity at positions surrounding a Ser/Thr phosphorylation site determined from arrayed PSPL analysis of <t>TLK2</t> ΔN178. The heat map shows normalized, log2 transformed PSPL spot intensities averaged across two separate experiments. Numerical values are provided in Supplementary Table . b Sequence logos showing positively selected residues were generated from the data shown in a using Seq2Logo . c Sequences of previously reported phosphorylation sites on human ASF1a and ASF1b. d Relative rates of TLK2 ΔN178 phosphorylation of a synthetic consensus peptide substrate (top) and Ala substitution variants (bars show mean ± SD, n = 4 independent experiments). e Representative assay showing TLK2 ΔN178 phosphorylation of purified GST-tagged ASF1b-CT (residues 155-202) and ASF1b-CT mutants was assessed in kinase assays in vitro. A kinase inactive TLK2-D592A mutant was included as a control. f Quantified results from three independent replicates of the experiment shown in panel e (mean ± SD) (right). g Electrostatic surface potential of the TLK2 and PKA catalytic domains (PDB 5O0Y and 1ATP ) with overlayed peptide fragment from the PKA-PKI complex (PDB 1ATP) generated using Pymol. h Phosphorylation of purified GST-tagged FL ASF1b (FL), the N-terminal domain (NT, residues 1–155) or the C-terminal tail (CT, residues 155–202) by purified FL TLK2 (WT or kinase inactive D592A mutant) was assessed using in vitro kinase assays. Results from one representative experiment of two are depicted, along with a cartoon depicting ASF1b domain organization and major sites of phosphorylation. Source data are provided as a Source Data file.
Initiator+ Alstra Peptide Synthesizer, supplied by BIOTAGE, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/all+peptides+were+produced+by+solid+state+synthesis+(fmoc+chemistry)/initiator++alstra+microwave+peptide+synthesizer/pmc10018684__ao3c00116_si_001-12-7-11
Average 90 stars, based on 1 article reviews
initiator+ alstra peptide synthesizer - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Advanced ChemTech apex 396 peptide synthesizer
a Heat map depicting amino acid selectivity at positions surrounding a Ser/Thr phosphorylation site determined from arrayed PSPL analysis of <t>TLK2</t> ΔN178. The heat map shows normalized, log2 transformed PSPL spot intensities averaged across two separate experiments. Numerical values are provided in Supplementary Table . b Sequence logos showing positively selected residues were generated from the data shown in a using Seq2Logo . c Sequences of previously reported phosphorylation sites on human ASF1a and ASF1b. d Relative rates of TLK2 ΔN178 phosphorylation of a synthetic consensus peptide substrate (top) and Ala substitution variants (bars show mean ± SD, n = 4 independent experiments). e Representative assay showing TLK2 ΔN178 phosphorylation of purified GST-tagged ASF1b-CT (residues 155-202) and ASF1b-CT mutants was assessed in kinase assays in vitro. A kinase inactive TLK2-D592A mutant was included as a control. f Quantified results from three independent replicates of the experiment shown in panel e (mean ± SD) (right). g Electrostatic surface potential of the TLK2 and PKA catalytic domains (PDB 5O0Y and 1ATP ) with overlayed peptide fragment from the PKA-PKI complex (PDB 1ATP) generated using Pymol. h Phosphorylation of purified GST-tagged FL ASF1b (FL), the N-terminal domain (NT, residues 1–155) or the C-terminal tail (CT, residues 155–202) by purified FL TLK2 (WT or kinase inactive D592A mutant) was assessed using in vitro kinase assays. Results from one representative experiment of two are depicted, along with a cartoon depicting ASF1b domain organization and major sites of phosphorylation. Source data are provided as a Source Data file.
Apex 396 Peptide Synthesizer, supplied by Advanced ChemTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/all+peptides+were+produced+by+solid+state+synthesis+(fmoc+chemistry)/apex+396+peptide+synthesizer/10__1021_slash_bm9007452-43-11-9
Average 90 stars, based on 1 article reviews
apex 396 peptide synthesizer - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
CS Bio Inc 136s peptide synthesizer
a Heat map depicting amino acid selectivity at positions surrounding a Ser/Thr phosphorylation site determined from arrayed PSPL analysis of <t>TLK2</t> ΔN178. The heat map shows normalized, log2 transformed PSPL spot intensities averaged across two separate experiments. Numerical values are provided in Supplementary Table . b Sequence logos showing positively selected residues were generated from the data shown in a using Seq2Logo . c Sequences of previously reported phosphorylation sites on human ASF1a and ASF1b. d Relative rates of TLK2 ΔN178 phosphorylation of a synthetic consensus peptide substrate (top) and Ala substitution variants (bars show mean ± SD, n = 4 independent experiments). e Representative assay showing TLK2 ΔN178 phosphorylation of purified GST-tagged ASF1b-CT (residues 155-202) and ASF1b-CT mutants was assessed in kinase assays in vitro. A kinase inactive TLK2-D592A mutant was included as a control. f Quantified results from three independent replicates of the experiment shown in panel e (mean ± SD) (right). g Electrostatic surface potential of the TLK2 and PKA catalytic domains (PDB 5O0Y and 1ATP ) with overlayed peptide fragment from the PKA-PKI complex (PDB 1ATP) generated using Pymol. h Phosphorylation of purified GST-tagged FL ASF1b (FL), the N-terminal domain (NT, residues 1–155) or the C-terminal tail (CT, residues 155–202) by purified FL TLK2 (WT or kinase inactive D592A mutant) was assessed using in vitro kinase assays. Results from one representative experiment of two are depicted, along with a cartoon depicting ASF1b domain organization and major sites of phosphorylation. Source data are provided as a Source Data file.
136s Peptide Synthesizer, supplied by CS Bio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/all+peptides+were+produced+by+solid+state+synthesis+(fmoc+chemistry)/automated+peptide+synthesizer+csbio+336s/bio_rxiv__2023__09__04__556216-132-13-12
Average 90 stars, based on 1 article reviews
136s peptide synthesizer - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
JPT Peptide Technologies GmbH all peptides with a purity above 70%
a Heat map depicting amino acid selectivity at positions surrounding a Ser/Thr phosphorylation site determined from arrayed PSPL analysis of <t>TLK2</t> ΔN178. The heat map shows normalized, log2 transformed PSPL spot intensities averaged across two separate experiments. Numerical values are provided in Supplementary Table . b Sequence logos showing positively selected residues were generated from the data shown in a using Seq2Logo . c Sequences of previously reported phosphorylation sites on human ASF1a and ASF1b. d Relative rates of TLK2 ΔN178 phosphorylation of a synthetic consensus peptide substrate (top) and Ala substitution variants (bars show mean ± SD, n = 4 independent experiments). e Representative assay showing TLK2 ΔN178 phosphorylation of purified GST-tagged ASF1b-CT (residues 155-202) and ASF1b-CT mutants was assessed in kinase assays in vitro. A kinase inactive TLK2-D592A mutant was included as a control. f Quantified results from three independent replicates of the experiment shown in panel e (mean ± SD) (right). g Electrostatic surface potential of the TLK2 and PKA catalytic domains (PDB 5O0Y and 1ATP ) with overlayed peptide fragment from the PKA-PKI complex (PDB 1ATP) generated using Pymol. h Phosphorylation of purified GST-tagged FL ASF1b (FL), the N-terminal domain (NT, residues 1–155) or the C-terminal tail (CT, residues 155–202) by purified FL TLK2 (WT or kinase inactive D592A mutant) was assessed using in vitro kinase assays. Results from one representative experiment of two are depicted, along with a cartoon depicting ASF1b domain organization and major sites of phosphorylation. Source data are provided as a Source Data file.
All Peptides With A Purity Above 70%, supplied by JPT Peptide Technologies GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/all+peptides+were+produced+by+solid+state+synthesis+(fmoc+chemistry)/all+peptides+with+a+purity+above+70+/pmc07458669-50-6-0
Average 90 stars, based on 1 article reviews
all peptides with a purity above 70% - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

95
Chem Impex International peptide synthesis
a Heat map depicting amino acid selectivity at positions surrounding a Ser/Thr phosphorylation site determined from arrayed PSPL analysis of <t>TLK2</t> ΔN178. The heat map shows normalized, log2 transformed PSPL spot intensities averaged across two separate experiments. Numerical values are provided in Supplementary Table . b Sequence logos showing positively selected residues were generated from the data shown in a using Seq2Logo . c Sequences of previously reported phosphorylation sites on human ASF1a and ASF1b. d Relative rates of TLK2 ΔN178 phosphorylation of a synthetic consensus peptide substrate (top) and Ala substitution variants (bars show mean ± SD, n = 4 independent experiments). e Representative assay showing TLK2 ΔN178 phosphorylation of purified GST-tagged ASF1b-CT (residues 155-202) and ASF1b-CT mutants was assessed in kinase assays in vitro. A kinase inactive TLK2-D592A mutant was included as a control. f Quantified results from three independent replicates of the experiment shown in panel e (mean ± SD) (right). g Electrostatic surface potential of the TLK2 and PKA catalytic domains (PDB 5O0Y and 1ATP ) with overlayed peptide fragment from the PKA-PKI complex (PDB 1ATP) generated using Pymol. h Phosphorylation of purified GST-tagged FL ASF1b (FL), the N-terminal domain (NT, residues 1–155) or the C-terminal tail (CT, residues 155–202) by purified FL TLK2 (WT or kinase inactive D592A mutant) was assessed using in vitro kinase assays. Results from one representative experiment of two are depicted, along with a cartoon depicting ASF1b domain organization and major sites of phosphorylation. Source data are provided as a Source Data file.
Peptide Synthesis, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/all+peptides+were+produced+by+solid+state+synthesis+(fmoc+chemistry)/Trifluoroacetic+acid/pm29319889-178-3-8
Average 95 stars, based on 1 article reviews
peptide synthesis - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

90
Advanced ChemTech fmoc solid phase synthesis materials
a Heat map depicting amino acid selectivity at positions surrounding a Ser/Thr phosphorylation site determined from arrayed PSPL analysis of <t>TLK2</t> ΔN178. The heat map shows normalized, log2 transformed PSPL spot intensities averaged across two separate experiments. Numerical values are provided in Supplementary Table . b Sequence logos showing positively selected residues were generated from the data shown in a using Seq2Logo . c Sequences of previously reported phosphorylation sites on human ASF1a and ASF1b. d Relative rates of TLK2 ΔN178 phosphorylation of a synthetic consensus peptide substrate (top) and Ala substitution variants (bars show mean ± SD, n = 4 independent experiments). e Representative assay showing TLK2 ΔN178 phosphorylation of purified GST-tagged ASF1b-CT (residues 155-202) and ASF1b-CT mutants was assessed in kinase assays in vitro. A kinase inactive TLK2-D592A mutant was included as a control. f Quantified results from three independent replicates of the experiment shown in panel e (mean ± SD) (right). g Electrostatic surface potential of the TLK2 and PKA catalytic domains (PDB 5O0Y and 1ATP ) with overlayed peptide fragment from the PKA-PKI complex (PDB 1ATP) generated using Pymol. h Phosphorylation of purified GST-tagged FL ASF1b (FL), the N-terminal domain (NT, residues 1–155) or the C-terminal tail (CT, residues 155–202) by purified FL TLK2 (WT or kinase inactive D592A mutant) was assessed using in vitro kinase assays. Results from one representative experiment of two are depicted, along with a cartoon depicting ASF1b domain organization and major sites of phosphorylation. Source data are provided as a Source Data file.
Fmoc Solid Phase Synthesis Materials, supplied by Advanced ChemTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/all+peptides+were+produced+by+solid+state+synthesis+(fmoc+chemistry)/fmoc+chemistry/pmc02970746-63-4-11
Average 90 stars, based on 1 article reviews
fmoc solid phase synthesis materials - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Advanced ChemTech synthesizer advanced chemtech 348 ω
a Heat map depicting amino acid selectivity at positions surrounding a Ser/Thr phosphorylation site determined from arrayed PSPL analysis of <t>TLK2</t> ΔN178. The heat map shows normalized, log2 transformed PSPL spot intensities averaged across two separate experiments. Numerical values are provided in Supplementary Table . b Sequence logos showing positively selected residues were generated from the data shown in a using Seq2Logo . c Sequences of previously reported phosphorylation sites on human ASF1a and ASF1b. d Relative rates of TLK2 ΔN178 phosphorylation of a synthetic consensus peptide substrate (top) and Ala substitution variants (bars show mean ± SD, n = 4 independent experiments). e Representative assay showing TLK2 ΔN178 phosphorylation of purified GST-tagged ASF1b-CT (residues 155-202) and ASF1b-CT mutants was assessed in kinase assays in vitro. A kinase inactive TLK2-D592A mutant was included as a control. f Quantified results from three independent replicates of the experiment shown in panel e (mean ± SD) (right). g Electrostatic surface potential of the TLK2 and PKA catalytic domains (PDB 5O0Y and 1ATP ) with overlayed peptide fragment from the PKA-PKI complex (PDB 1ATP) generated using Pymol. h Phosphorylation of purified GST-tagged FL ASF1b (FL), the N-terminal domain (NT, residues 1–155) or the C-terminal tail (CT, residues 155–202) by purified FL TLK2 (WT or kinase inactive D592A mutant) was assessed using in vitro kinase assays. Results from one representative experiment of two are depicted, along with a cartoon depicting ASF1b domain organization and major sites of phosphorylation. Source data are provided as a Source Data file.
Synthesizer Advanced Chemtech 348 ω, supplied by Advanced ChemTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/all+peptides+were+produced+by+solid+state+synthesis+(fmoc+chemistry)/chemtech+348+%CF%89+synthesizer/pmc04699573-269-7-5
Average 90 stars, based on 1 article reviews
synthesizer advanced chemtech 348 ω - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


a Heat map depicting amino acid selectivity at positions surrounding a Ser/Thr phosphorylation site determined from arrayed PSPL analysis of TLK2 ΔN178. The heat map shows normalized, log2 transformed PSPL spot intensities averaged across two separate experiments. Numerical values are provided in Supplementary Table . b Sequence logos showing positively selected residues were generated from the data shown in a using Seq2Logo . c Sequences of previously reported phosphorylation sites on human ASF1a and ASF1b. d Relative rates of TLK2 ΔN178 phosphorylation of a synthetic consensus peptide substrate (top) and Ala substitution variants (bars show mean ± SD, n = 4 independent experiments). e Representative assay showing TLK2 ΔN178 phosphorylation of purified GST-tagged ASF1b-CT (residues 155-202) and ASF1b-CT mutants was assessed in kinase assays in vitro. A kinase inactive TLK2-D592A mutant was included as a control. f Quantified results from three independent replicates of the experiment shown in panel e (mean ± SD) (right). g Electrostatic surface potential of the TLK2 and PKA catalytic domains (PDB 5O0Y and 1ATP ) with overlayed peptide fragment from the PKA-PKI complex (PDB 1ATP) generated using Pymol. h Phosphorylation of purified GST-tagged FL ASF1b (FL), the N-terminal domain (NT, residues 1–155) or the C-terminal tail (CT, residues 155–202) by purified FL TLK2 (WT or kinase inactive D592A mutant) was assessed using in vitro kinase assays. Results from one representative experiment of two are depicted, along with a cartoon depicting ASF1b domain organization and major sites of phosphorylation. Source data are provided as a Source Data file.

Journal: Nature Communications

Article Title: Tousled-like kinase 2 targets ASF1 histone chaperones through client mimicry

doi: 10.1038/s41467-022-28427-0

Figure Lengend Snippet: a Heat map depicting amino acid selectivity at positions surrounding a Ser/Thr phosphorylation site determined from arrayed PSPL analysis of TLK2 ΔN178. The heat map shows normalized, log2 transformed PSPL spot intensities averaged across two separate experiments. Numerical values are provided in Supplementary Table . b Sequence logos showing positively selected residues were generated from the data shown in a using Seq2Logo . c Sequences of previously reported phosphorylation sites on human ASF1a and ASF1b. d Relative rates of TLK2 ΔN178 phosphorylation of a synthetic consensus peptide substrate (top) and Ala substitution variants (bars show mean ± SD, n = 4 independent experiments). e Representative assay showing TLK2 ΔN178 phosphorylation of purified GST-tagged ASF1b-CT (residues 155-202) and ASF1b-CT mutants was assessed in kinase assays in vitro. A kinase inactive TLK2-D592A mutant was included as a control. f Quantified results from three independent replicates of the experiment shown in panel e (mean ± SD) (right). g Electrostatic surface potential of the TLK2 and PKA catalytic domains (PDB 5O0Y and 1ATP ) with overlayed peptide fragment from the PKA-PKI complex (PDB 1ATP) generated using Pymol. h Phosphorylation of purified GST-tagged FL ASF1b (FL), the N-terminal domain (NT, residues 1–155) or the C-terminal tail (CT, residues 155–202) by purified FL TLK2 (WT or kinase inactive D592A mutant) was assessed using in vitro kinase assays. Results from one representative experiment of two are depicted, along with a cartoon depicting ASF1b domain organization and major sites of phosphorylation. Source data are provided as a Source Data file.

Article Snippet: All other peptides were custom synthesized by Genscript at >98% purity (TLK2, histone H3 and HIRA peptides) or >95% purity (kinase assay substrates).

Techniques: Transformation Assay, Sequencing, Generated, Purification, In Vitro, Mutagenesis

a , b GFP, GFP-TLK2, or kinase-inactive GFP-TLK2 (D592A) was co-expressed with FLAG-tagged ASF1a in HEK293T cells, cells were lysed and GFP proteins were precipitated with anti-GFP nanobodies coupled to Sepharose beads. Precipitated GFP proteins and co-precipitating FLAG-ASF1a were fractionated by SDS-PAGE and detected by immunoblotting. A representative experiment is shown in a . Relative ASF1a binding, normalized for FLAG-ASF1a input was quantified in 11 independent replicates, and mean ± SD is shown in b . Both unphosphorylated and phosphorylated forms of ASF1 were included in the analysis. **** p values < 0.0001 in one-way ANOVA with Tukey’s multiple comparison test. c Cartoon depicting TLK2 domain organization. Amino acid numbers are indicated. d – g GFP-TLK2 (D592A) and N-terminal or C-terminal TLK2 deletion constructs were expressed in HEK293T cells, GFP-nanobody pulldowns were performed as in a and co-precipitating endogenous ASF1a was detected by immunoblotting. Representative experiments are shown in d and f . and mean ± SD of three independent replicates are quantified in e and g . Significant difference from GFP-TLK2 D592A (1–772) calculated in one-way ANOVA with Dunnett’s multiple comparison test— p values shown on graph. Source data are provided as a Source Data file.

Journal: Nature Communications

Article Title: Tousled-like kinase 2 targets ASF1 histone chaperones through client mimicry

doi: 10.1038/s41467-022-28427-0

Figure Lengend Snippet: a , b GFP, GFP-TLK2, or kinase-inactive GFP-TLK2 (D592A) was co-expressed with FLAG-tagged ASF1a in HEK293T cells, cells were lysed and GFP proteins were precipitated with anti-GFP nanobodies coupled to Sepharose beads. Precipitated GFP proteins and co-precipitating FLAG-ASF1a were fractionated by SDS-PAGE and detected by immunoblotting. A representative experiment is shown in a . Relative ASF1a binding, normalized for FLAG-ASF1a input was quantified in 11 independent replicates, and mean ± SD is shown in b . Both unphosphorylated and phosphorylated forms of ASF1 were included in the analysis. **** p values < 0.0001 in one-way ANOVA with Tukey’s multiple comparison test. c Cartoon depicting TLK2 domain organization. Amino acid numbers are indicated. d – g GFP-TLK2 (D592A) and N-terminal or C-terminal TLK2 deletion constructs were expressed in HEK293T cells, GFP-nanobody pulldowns were performed as in a and co-precipitating endogenous ASF1a was detected by immunoblotting. Representative experiments are shown in d and f . and mean ± SD of three independent replicates are quantified in e and g . Significant difference from GFP-TLK2 D592A (1–772) calculated in one-way ANOVA with Dunnett’s multiple comparison test— p values shown on graph. Source data are provided as a Source Data file.

Article Snippet: All other peptides were custom synthesized by Genscript at >98% purity (TLK2, histone H3 and HIRA peptides) or >95% purity (kinase assay substrates).

Techniques: SDS Page, Western Blot, Binding Assay, Construct

a , b GFP, GFP-TLK2 (D592A) full-length (1–772) or N-terminal truncations (123–772 or 24–772) were expressed in HEK293T cells. Precipitated GFP proteins and co-precipitating endogenous ASF1a were fractionated by SDS-PAGE and detected by immunoblotting. A representative experiment is shown in a . Relative ASF1a binding normalized to full-length GFP-TLK2 (D592A) was quantified in three independent replicates and mean ± S.D is shown in b . c DSF was used to determine the melting temperature of purified ASF1a 1–155 in the presence or absence of 160 μM TLK2 peptide spanning residues 3–23. Mean ± SD of three independent replicates are shown. d FP assay to assess the interaction of the TLK2 peptide with purified recombinant ASF1a-NT. Increasing concentrations of unlabeled TLK2 peptide were titrated into a mixture of a fixed concentration of fluorescently labeled TLK2 peptide and purified recombinant ASF1a-NT, and FP was assessed. Results are shown as mean ± SD of independent experiments ( n = 3 for competitor peptide concentrations 0–32 μM, n = 2 for 64–256 μM). Source data are provided as a Source Data file.

Journal: Nature Communications

Article Title: Tousled-like kinase 2 targets ASF1 histone chaperones through client mimicry

doi: 10.1038/s41467-022-28427-0

Figure Lengend Snippet: a , b GFP, GFP-TLK2 (D592A) full-length (1–772) or N-terminal truncations (123–772 or 24–772) were expressed in HEK293T cells. Precipitated GFP proteins and co-precipitating endogenous ASF1a were fractionated by SDS-PAGE and detected by immunoblotting. A representative experiment is shown in a . Relative ASF1a binding normalized to full-length GFP-TLK2 (D592A) was quantified in three independent replicates and mean ± S.D is shown in b . c DSF was used to determine the melting temperature of purified ASF1a 1–155 in the presence or absence of 160 μM TLK2 peptide spanning residues 3–23. Mean ± SD of three independent replicates are shown. d FP assay to assess the interaction of the TLK2 peptide with purified recombinant ASF1a-NT. Increasing concentrations of unlabeled TLK2 peptide were titrated into a mixture of a fixed concentration of fluorescently labeled TLK2 peptide and purified recombinant ASF1a-NT, and FP was assessed. Results are shown as mean ± SD of independent experiments ( n = 3 for competitor peptide concentrations 0–32 μM, n = 2 for 64–256 μM). Source data are provided as a Source Data file.

Article Snippet: All other peptides were custom synthesized by Genscript at >98% purity (TLK2, histone H3 and HIRA peptides) or >95% purity (kinase assay substrates).

Techniques: SDS Page, Western Blot, Binding Assay, Purification, FP Assay, Recombinant, Concentration Assay, Labeling

Data collection and refinement statistics (molecular replacement).

Journal: Nature Communications

Article Title: Tousled-like kinase 2 targets ASF1 histone chaperones through client mimicry

doi: 10.1038/s41467-022-28427-0

Figure Lengend Snippet: Data collection and refinement statistics (molecular replacement).

Article Snippet: All other peptides were custom synthesized by Genscript at >98% purity (TLK2, histone H3 and HIRA peptides) or >95% purity (kinase assay substrates).

Techniques:

Cartoon depictions of the structure of one molecule of the NT domain of human ASF1a (gray) ( a ) or of one molecule of the NT domain of human ASF1a bound to N-terminal peptides from TLK2 (ASF1a—gray; TLK2—beige and purple) ( b ). c Cartoon depicting known interaction surfaces on ASF1a and their interaction with partners based on PDB code 2I32 and 2IO5 . ASF1a—gray, histone H3—cyan, histone H4—green, HIRA—yellow. d , e Detail of TLK2 binding ASF1a at the H3-binding site ( d ) and comparison with the equivalent ASF1a-H3-H4 interaction ( e ), colored as in b and c .

Journal: Nature Communications

Article Title: Tousled-like kinase 2 targets ASF1 histone chaperones through client mimicry

doi: 10.1038/s41467-022-28427-0

Figure Lengend Snippet: Cartoon depictions of the structure of one molecule of the NT domain of human ASF1a (gray) ( a ) or of one molecule of the NT domain of human ASF1a bound to N-terminal peptides from TLK2 (ASF1a—gray; TLK2—beige and purple) ( b ). c Cartoon depicting known interaction surfaces on ASF1a and their interaction with partners based on PDB code 2I32 and 2IO5 . ASF1a—gray, histone H3—cyan, histone H4—green, HIRA—yellow. d , e Detail of TLK2 binding ASF1a at the H3-binding site ( d ) and comparison with the equivalent ASF1a-H3-H4 interaction ( e ), colored as in b and c .

Article Snippet: All other peptides were custom synthesized by Genscript at >98% purity (TLK2, histone H3 and HIRA peptides) or >95% purity (kinase assay substrates).

Techniques: Binding Assay

a , b Cells were co-transfected with FLAG-tagged ASF1a and GFP-tagged kinase-inactive TLK2 (D592A) or GFP-TLK2 (D592A) containing additional mutations at the structurally defined ASF1a-binding site and anti-GFP nanobody pulldown assays were performed. Precipitated GFP proteins and co-precipitating FLAG-ASF1a were fractionated by SDS-PAGE and detected by immunoblotting. A representative experiment is shown in a . Relative ASF1a binding, corrected for FLAG-ASF1a input and normalized to GFP-TLK2 (D592A) was quantified, and mean ± SD ( n = 6 independent experiments) is shown in b . p values in one-way ANOVA with Dunnett’s multiple comparison correction are indicated. c , d Pulldown assays were performed as in A from cells co-expressing GFP-TLK2 (D592A) and WT or mutant FLAG-tagged ASF1a. A representative experiment is shown in c . Relative ASF1a binding, normalized for FLAG-ASF1 input was quantified in five independent replicates and mean ± SD is shown in d . p values in one-way ANOVA with Dunnett’s multiple comparison correction are indicated. e Competitive FP assays of peptide binding to ASF1a-NT were performed as in Fig. . Peptides correspond to the ASF1-binding fragments of human histone H3.1 (120–135) and HIRA (446–464). TLK2pep-AAA is the TLK2 N-terminal peptide harboring L16A/R19A/F20A substitutions. Results are shown as mean ± SD ( n = 3 biologically independent experiments). Source data are provided as a Source Data file.

Journal: Nature Communications

Article Title: Tousled-like kinase 2 targets ASF1 histone chaperones through client mimicry

doi: 10.1038/s41467-022-28427-0

Figure Lengend Snippet: a , b Cells were co-transfected with FLAG-tagged ASF1a and GFP-tagged kinase-inactive TLK2 (D592A) or GFP-TLK2 (D592A) containing additional mutations at the structurally defined ASF1a-binding site and anti-GFP nanobody pulldown assays were performed. Precipitated GFP proteins and co-precipitating FLAG-ASF1a were fractionated by SDS-PAGE and detected by immunoblotting. A representative experiment is shown in a . Relative ASF1a binding, corrected for FLAG-ASF1a input and normalized to GFP-TLK2 (D592A) was quantified, and mean ± SD ( n = 6 independent experiments) is shown in b . p values in one-way ANOVA with Dunnett’s multiple comparison correction are indicated. c , d Pulldown assays were performed as in A from cells co-expressing GFP-TLK2 (D592A) and WT or mutant FLAG-tagged ASF1a. A representative experiment is shown in c . Relative ASF1a binding, normalized for FLAG-ASF1 input was quantified in five independent replicates and mean ± SD is shown in d . p values in one-way ANOVA with Dunnett’s multiple comparison correction are indicated. e Competitive FP assays of peptide binding to ASF1a-NT were performed as in Fig. . Peptides correspond to the ASF1-binding fragments of human histone H3.1 (120–135) and HIRA (446–464). TLK2pep-AAA is the TLK2 N-terminal peptide harboring L16A/R19A/F20A substitutions. Results are shown as mean ± SD ( n = 3 biologically independent experiments). Source data are provided as a Source Data file.

Article Snippet: All other peptides were custom synthesized by Genscript at >98% purity (TLK2, histone H3 and HIRA peptides) or >95% purity (kinase assay substrates).

Techniques: Transfection, Binding Assay, SDS Page, Western Blot, Expressing, Mutagenesis

a , b Purified GST tagged ASF1a WT, indicated mutants, or C-terminal tail residues 155–204 (CT) were phosphorylated by WT TLK2 or the indicated mutants with [γ- 32 P]ATP. Samples were subjected to SDS-PAGE followed by phosphor imaging. A representative experiment is shown in a . Quantified radiolabel incorporation for each of three independent replicates (mean ± SD) is shown relative to the level of phosphorylation of ASF1a-CT by the indicated form of TLK2. Source data are provided as a Source Data file.

Journal: Nature Communications

Article Title: Tousled-like kinase 2 targets ASF1 histone chaperones through client mimicry

doi: 10.1038/s41467-022-28427-0

Figure Lengend Snippet: a , b Purified GST tagged ASF1a WT, indicated mutants, or C-terminal tail residues 155–204 (CT) were phosphorylated by WT TLK2 or the indicated mutants with [γ- 32 P]ATP. Samples were subjected to SDS-PAGE followed by phosphor imaging. A representative experiment is shown in a . Quantified radiolabel incorporation for each of three independent replicates (mean ± SD) is shown relative to the level of phosphorylation of ASF1a-CT by the indicated form of TLK2. Source data are provided as a Source Data file.

Article Snippet: All other peptides were custom synthesized by Genscript at >98% purity (TLK2, histone H3 and HIRA peptides) or >95% purity (kinase assay substrates).

Techniques: Purification, SDS Page, Imaging

a , b FLAG-tagged ASF1a was transiently co-expressed in HEK 293T cells with GFP, or GFP-tagged WT or mutant TLK2. After 24 h, cells were lysed, fractionated by SDS-PAGE and immunoblotted with anti-GFP and anti-FLAG antibodies. The extent of FLAG-tagged ASF1a phosphorylation was calculated as the ratio of slower migrating species to total FLAG signal in four independent replicates, and mean ± SD is shown in b . Values significantly different from GFP-TLK2 in one-way ANOVA with Dunnett’s multiple comparison test are indicated **** p < 0.001. c , d TLK2 and ASF1a were detected by immunoblotting lysates of control (Ctrl) or TLK2-knockout (sgTLK2) MCF7 cells that stably express WT or mutant TLK2 or luciferase (Luc) as a control. ASF1a phosphorylation was calculated by electrophoretic mobility shift in three independent replicates and mean ± SD is shown in d . p values of significant differences from Ctrl + Luc value in one-way ANOVA with Dunnett’s multiple comparison test are indicated. e , f The ability of control or TLK2 knockout cells expressing luciferase, WT, or mutant TLK2 to form colonies after 2 weeks of culture was assessed and quantified. Representative images of crystal violet-stained cells visualized with a LiCor Odyssey scanner are shown in e and quantification of three independent experiments normalized to the sgTLK2 + TLK2 WT value (mean ± SD) is shown in f . Values significantly different from sgTLK2 cells expressing WT TLK2 in one-way ANOVA with Dunnett’s multiple comparison test are indicated. Source data are provided as a Source Data file.

Journal: Nature Communications

Article Title: Tousled-like kinase 2 targets ASF1 histone chaperones through client mimicry

doi: 10.1038/s41467-022-28427-0

Figure Lengend Snippet: a , b FLAG-tagged ASF1a was transiently co-expressed in HEK 293T cells with GFP, or GFP-tagged WT or mutant TLK2. After 24 h, cells were lysed, fractionated by SDS-PAGE and immunoblotted with anti-GFP and anti-FLAG antibodies. The extent of FLAG-tagged ASF1a phosphorylation was calculated as the ratio of slower migrating species to total FLAG signal in four independent replicates, and mean ± SD is shown in b . Values significantly different from GFP-TLK2 in one-way ANOVA with Dunnett’s multiple comparison test are indicated **** p < 0.001. c , d TLK2 and ASF1a were detected by immunoblotting lysates of control (Ctrl) or TLK2-knockout (sgTLK2) MCF7 cells that stably express WT or mutant TLK2 or luciferase (Luc) as a control. ASF1a phosphorylation was calculated by electrophoretic mobility shift in three independent replicates and mean ± SD is shown in d . p values of significant differences from Ctrl + Luc value in one-way ANOVA with Dunnett’s multiple comparison test are indicated. e , f The ability of control or TLK2 knockout cells expressing luciferase, WT, or mutant TLK2 to form colonies after 2 weeks of culture was assessed and quantified. Representative images of crystal violet-stained cells visualized with a LiCor Odyssey scanner are shown in e and quantification of three independent experiments normalized to the sgTLK2 + TLK2 WT value (mean ± SD) is shown in f . Values significantly different from sgTLK2 cells expressing WT TLK2 in one-way ANOVA with Dunnett’s multiple comparison test are indicated. Source data are provided as a Source Data file.

Article Snippet: All other peptides were custom synthesized by Genscript at >98% purity (TLK2, histone H3 and HIRA peptides) or >95% purity (kinase assay substrates).

Techniques: Mutagenesis, SDS Page, Western Blot, Knock-Out, Stable Transfection, Luciferase, Electrophoretic Mobility Shift Assay, Expressing, Staining